Novel oncolytic adenoviral vectors
CA 2439115 A1 · Owner: Police, Seshidhar Reddy · Inventors: Phipps, Sandrina; Ennist, David Leonard; Jakubczak, John Leonard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to oncolytic adenoviral vectors and their use in methods of gene therapy. Provided is a recombinant viral vector comprising an adenoviral nucleic acid backbone, wherein said nucleic acid backbone comprises in sequential order : A left ITR, a termination signal sequence an E2F , responsive promoter which is operably linked to a gene essential for replication of the recombinant viral vector an adenoviral packaging signal, and a right ITR.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 22, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.